Roger Golomb, MD
Procedural Dermatology · Clearwater, FLNPI 1841282340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,163 and has fallen 68.7% since, to $363 in 2025.
Across 151 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$740
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$600
- Sun Pharmaceutical Industries Inc.$386
- AbbVie$293
- Regeneron Healthcare Solutions, Inc.$253
- Arcutis Biotherapeutics, Inc.$212
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $740 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $600 |
| Sun Pharmaceutical Industries Inc. | 16 | $386 |
| AbbVie | 13 | $293 |
| Regeneron Healthcare Solutions, Inc. | 8 | $253 |
| Arcutis Biotherapeutics, Inc. | 1 | $212 |
| Lilly USA, LLC | 9 | $202 |
| Dermavant Sciences, Inc. | 6 | $182 |
| Johnson & Johnson | 10 | $153 |
| Sanofi | 4 | $122 |
| E.r. Squibb & Sons, L.L.C. | 5 | $111 |
| Janssen Scientific Affairs, LLC | 1 | $109 |
| Kyowa Kirin, Inc. | 4 | $86 |
| UCB, Inc. | 2 | $75 |
| Pfizer | 1 | $71 |
| Organogenesis Inc. | 2 | $55 |
| Strata Skin Sciences, Inc. | 2 | $53 |
| Incyte Corporation | 2 | $40 |
| LEO Pharma Inc. | 2 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Boehringer Ingelheim | 1 | $33 |
| Amgen | 1 | $32 |
| Genentech USA, Inc. | 1 | $27 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Next Science LLC | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| Penumbra, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Dermira, Inc. | 1 | $17 |
| DUSA Pharmaceuticals, Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,123 in reported general payments places this provider in the 75th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 38 | $138,704 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $106,338 |
| Humira(Cf) PenAdalimumab | 13 | $85,162 |
| Fluorouracil | 30 | $2,577 |
| Clobetasol Propionate | 53 | $1,693 |
| Betamethasone Dipropionate | 38 | $1,425 |
| Fluocinonide | 19 | $1,164 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 13 | $1,120 |
| Triamcinolone Acetonide | 97 | $655 |
| Clindamycin Phosphate | 20 | $552 |
| Mometasone Furoate | 37 | $459 |
| Ketoconazole | 33 | $369 |
| Doxycycline Hyclate | 23 | $314 |
| ValacyclovirValacyclovir Hcl | 12 | $122 |
| Hydrocortisone | 19 | $96 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Clearwater
- Phyllis MurphyClearwater$60
- Luis SoroFort Lauderdale$307K
- Laertes ManuelidisFort Myers$252K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Dimitry PalceskiWinter Park$23K
- Samantha MarroneOrlando$22K
- Robert BrownOrange Park$22K
- Ileana Perez-QuintairosSouth Miami$16K
- Lawrence StrongWellington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.